Global Neurological Biomarkers Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Neurological Biomarkers Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type
  • 1.4.2 Proteomics
  • 1.4.3 Genomics
  • 1.2.4 Imaging
  • 1.2.5 Bioinformatics
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application
  • 1.3.2 Diagnostics
  • 1.3.3 Drug Discovery
  • 1.3.4 Personalized Medicine
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Neurological Biomarkers Sales Estimates and Forecasts 2016-2027
• 2.2 Global Neurological Biomarkers Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Neurological Biomarkers Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Neurological Biomarkers Regions by Sales
  • 2.4.1 Global Top Neurological Biomarkers Regions by Sales (2016-2021)
  • 2.4.2 Global Top Neurological Biomarkers Regions by Sales (2022-2027)
• 2.5 Global Top Neurological Biomarkers Regions by Revenue
  • 2.5.1 Global Top Neurological Biomarkers Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Neurological Biomarkers Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Neurological Biomarkers Sales by Manufacturers
  • 3.1.1 Global Top Neurological Biomarkers Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Neurological Biomarkers Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Neurological Biomarkers Sales in 2020
• 3.2 Global Neurological Biomarkers Revenue by Manufacturers
  • 3.2.1 Global Top Neurological Biomarkers Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Neurological Biomarkers Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Neurological Biomarkers Revenue in 2020
• 3.3 Global Neurological Biomarkers Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Neurological Biomarkers Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Neurological Biomarkers Sales by Type
  • 4.1.1 Global Neurological Biomarkers Historical Sales by Type (2016-2021)
  • 4.1.2 Global Neurological Biomarkers Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Neurological Biomarkers Sales Market Share by Type (2016-2027)
• 4.2 Global Neurological Biomarkers Revenue by Type
  • 4.2.1 Global Neurological Biomarkers Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Neurological Biomarkers Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2016-2027)
• 4.3 Global Neurological Biomarkers Price by Type
  • 4.3.1 Global Neurological Biomarkers Price by Type (2016-2021)
  • 4.3.2 Global Neurological Biomarkers Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Neurological Biomarkers Sales by Application
  • 5.1.1 Global Neurological Biomarkers Historical Sales by Application (2016-2021)
  • 5.1.2 Global Neurological Biomarkers Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Neurological Biomarkers Sales Market Share by Application (2016-2027)
• 5.2 Global Neurological Biomarkers Revenue by Application
  • 5.2.1 Global Neurological Biomarkers Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Neurological Biomarkers Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2016-2027)
• 5.3 Global Neurological Biomarkers Price by Application
  • 5.3.1 Global Neurological Biomarkers Price by Application (2016-2021)
  • 5.3.2 Global Neurological Biomarkers Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Neurological Biomarkers Market Size by Type
  • 6.1.1 North America Neurological Biomarkers Sales by Type (2016-2027)
  • 6.1.2 North America Neurological Biomarkers Revenue by Type (2016-2027)
• 6.2 North America Neurological Biomarkers Market Size by Application
  • 6.2.1 North America Neurological Biomarkers Sales by Application (2016-2027)
  • 6.2.2 North America Neurological Biomarkers Revenue by Application (2016-2027)
• 6.3 North America Neurological Biomarkers Market Size by Country
  • 6.3.1 North America Neurological Biomarkers Sales by Country (2016-2027)
  • 6.3.2 North America Neurological Biomarkers Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Neurological Biomarkers Market Size by Type
  • 7.1.1 Europe Neurological Biomarkers Sales by Type (2017-2027)
  • 7.1.2 Europe Neurological Biomarkers Revenue by Type (2017-2027)
• 7.2 Europe Neurological Biomarkers Market Size by Application
  • 7.2.1 Europe Neurological Biomarkers Sales by Application (2017-2027)
  • 7.2.2 Europe Neurological Biomarkers Revenue by Application (2017-2027)
• 7.3 Europe Neurological Biomarkers Market Size by Country
  • 7.3.1 Europe Neurological Biomarkers Sales by Country (2017-2027)
  • 7.3.2 Europe Neurological Biomarkers Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Neurological Biomarkers Market Size by Type
  • 8.1.1 Asia Pacific Neurological Biomarkers Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Neurological Biomarkers Revenue by Type (2018-2027)
• 8.2 Asia Pacific Neurological Biomarkers Market Size by Application
  • 8.2.1 Asia Pacific Neurological Biomarkers Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Neurological Biomarkers Revenue by Application (2018-2027)
• 8.3 Asia Pacific Neurological Biomarkers Market Size by Region
  • 8.3.1 Asia Pacific Neurological Biomarkers Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Neurological Biomarkers Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Neurological Biomarkers Market Size by Type
  • 9.1.1 Latin America Neurological Biomarkers Sales by Type (2019-2027)
  • 9.1.2 Latin America Neurological Biomarkers Revenue by Type (2019-2027)
• 9.2 Latin America Neurological Biomarkers Market Size by Application
  • 9.2.1 Latin America Neurological Biomarkers Sales by Application (2019-2027)
  • 9.2.2 Latin America Neurological Biomarkers Revenue by Application (2019-2027)
• 9.3 Latin America Neurological Biomarkers Market Size by Country
  • 9.3.1 Latin America Neurological Biomarkers Sales by Country (2019-2027)
  • 9.3.2 Latin America Neurological Biomarkers Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Neurological Biomarkers Market Size by Type
  • 6.1.1 Middle East and Africa Neurological Biomarkers Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Neurological Biomarkers Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Neurological Biomarkers Market Size by Application
  • 6.2.1 Middle East and Africa Neurological Biomarkers Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Neurological Biomarkers Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Neurological Biomarkers Market Size by Country
  • 6.3.1 Middle East and Africa Neurological Biomarkers Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Corporation Information
  • 11.1.2 Thermo Fisher Scientific Overview
  • 11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Description
  • 11.1.5 Thermo Fisher Scientific Related Developments
• 11.2 Merck
  • 11.2.1 Merck Corporation Information
  • 11.2.2 Merck Overview
  • 11.2.3 Merck Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Merck Neurological Biomarkers Product Description
  • 11.2.5 Merck Related Developments
• 11.3 Quest Diagnostics
  • 11.3.1 Quest Diagnostics Corporation Information
  • 11.3.2 Quest Diagnostics Overview
  • 11.3.3 Quest Diagnostics Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Quest Diagnostics Neurological Biomarkers Product Description
  • 11.3.5 Quest Diagnostics Related Developments
• 11.4 Abbott
  • 11.4.1 Abbott Corporation Information
  • 11.4.2 Abbott Overview
  • 11.4.3 Abbott Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Abbott Neurological Biomarkers Product Description
  • 11.4.5 Abbott Related Developments
• 11.5 Roche
  • 11.5.1 Roche Corporation Information
  • 11.5.2 Roche Overview
  • 11.5.3 Roche Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Roche Neurological Biomarkers Product Description
  • 11.5.5 Roche Related Developments
• 11.6 Illumina
  • 11.6.1 Illumina Corporation Information
  • 11.6.2 Illumina Overview
  • 11.6.3 Illumina Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Illumina Neurological Biomarkers Product Description
  • 11.6.5 Illumina Related Developments
• 11.7 Bio-Rad Laboratories
  • 11.7.1 Bio-Rad Laboratories Corporation Information
  • 11.7.2 Bio-Rad Laboratories Overview
  • 11.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Bio-Rad Laboratories Neurological Biomarkers Product Description
  • 11.7.5 Bio-Rad Laboratories Related Developments
• 11.8 QIAGEN
  • 11.8.1 QIAGEN Corporation Information
  • 11.8.2 QIAGEN Overview
  • 11.8.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 QIAGEN Neurological Biomarkers Product Description
  • 11.8.5 QIAGEN Related Developments
• 11.9 Myriad RBM
  • 11.9.1 Myriad RBM Corporation Information
  • 11.9.2 Myriad RBM Overview
  • 11.9.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Myriad RBM Neurological Biomarkers Product Description
  • 11.9.5 Myriad RBM Related Developments
• 11.10 Cisbio Bioassays
  • 11.10.1 Cisbio Bioassays Corporation Information
  • 11.10.2 Cisbio Bioassays Overview
  • 11.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Cisbio Bioassays Neurological Biomarkers Product Description
  • 11.10.5 Cisbio Bioassays Related Developments
• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Corporation Information
  • 11.1.2 Thermo Fisher Scientific Overview
  • 11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Description
  • 11.1.5 Thermo Fisher Scientific Related Developments
• 11.12 BGI
  • 11.12.1 BGI Corporation Information
  • 11.12.2 BGI Overview
  • 11.12.3 BGI Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 BGI Product Description
  • 11.12.5 BGI Related Developments
• 11.13 Wuxi APP
  • 11.13.1 Wuxi APP Corporation Information
  • 11.13.2 Wuxi APP Overview
  • 11.13.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Wuxi APP Product Description
  • 11.13.5 Wuxi APP Related Developments
• 11.14 Aepodia
  • 11.14.1 Aepodia Corporation Information
  • 11.14.2 Aepodia Overview
  • 11.14.3 Aepodia Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Aepodia Product Description
  • 11.14.5 Aepodia Related Developments
• 11.15 Proteome Sciences
  • 11.15.1 Proteome Sciences Corporation Information
  • 11.15.2 Proteome Sciences Overview
  • 11.15.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Proteome Sciences Product Description
  • 11.15.5 Proteome Sciences Related Developments
• 11.16 Genewiz
  • 11.16.1 Genewiz Corporation Information
  • 11.16.2 Genewiz Overview
  • 11.16.3 Genewiz Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 Genewiz Product Description
  • 11.16.5 Genewiz Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Neurological Biomarkers Value Chain Analysis
• 12.2 Neurological Biomarkers Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Neurological Biomarkers Production Mode & Process
• 12.4 Neurological Biomarkers Sales and Marketing
  • 12.4.1 Neurological Biomarkers Sales Channels
  • 12.4.2 Neurological Biomarkers Distributors
• 12.5 Neurological Biomarkers Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Neurological Biomarkers Industry Trends
• 13.2 Neurological Biomarkers Market Drivers
• 13.3 Neurological Biomarkers Market Challenges
• 13.4 Neurological Biomarkers Market Restraints

14 Key Findings in The Global Neurological Biomarkers Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details